These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30255545)
1. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5). Seibel NL; Chi YY; Perlman EJ; Tian J; Sun J; Anderson JR; Ritchey ML; Thomas PR; Miser J; Kalapurakal JA; Grundy PE; Green DM Pediatr Blood Cancer; 2019 Jan; 66(1):e27450. PubMed ID: 30255545 [TBL] [Abstract][Full Text] [Related]
2. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Benedetti DJ; Renfro LA; Tfirn I; Daw NC; Kalapurakal JA; Ehrlich PF; Khanna G; Perlman E; Warwick A; Gow KW; Paulino AC; Seibel NL; Grundy P; Fernandez CV; Geller JI; Mullen EA; Dome JS Cancer; 2024 Jul; 130(13):2361-2371. PubMed ID: 38396300 [TBL] [Abstract][Full Text] [Related]
3. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069 [TBL] [Abstract][Full Text] [Related]
4. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5. Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of children with clear cell sarcoma of kidney following NWTS strategies in Shanghai China (2003-2021). Zhang A; Yuan X; Jiang S; Xu D; Huang C; Tang JY; Gao Y PLoS One; 2024; 19(7):e0306863. PubMed ID: 38980838 [TBL] [Abstract][Full Text] [Related]
7. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study. Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE; Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826 [TBL] [Abstract][Full Text] [Related]
8. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. Green DM; Breslow NE; Beckwith JB; Moksness J; Finklestein JZ; D'Angio GJ J Clin Oncol; 1994 Oct; 12(10):2132-7. PubMed ID: 7931484 [TBL] [Abstract][Full Text] [Related]
9. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. Dix DB; Seibel NL; Chi YY; Khanna G; Gratias E; Anderson JR; Mullen EA; Geller JI; Kalapurakal JA; Paulino AC; Perlman EJ; Ehrlich PF; Malogolowkin M; Gastier-Foster JM; Wagner E; Grundy PE; Fernandez CV; Dome JS J Clin Oncol; 2018 Jun; 36(16):1564-1570. PubMed ID: 29659330 [TBL] [Abstract][Full Text] [Related]
11. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D; Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021 [TBL] [Abstract][Full Text] [Related]
13. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795 [TBL] [Abstract][Full Text] [Related]
14. Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study. Gooskens SL; Furtwängler R; Spreafico F; van Tinteren H; de Kraker J; Vujanic GM; Leuschner I; Coulomb-L'Herminé A; Godzinski J; Schleiermacher G; Stoneham S; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM Br J Cancer; 2014 Jul; 111(2):227-33. PubMed ID: 24937667 [TBL] [Abstract][Full Text] [Related]
15. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483 [TBL] [Abstract][Full Text] [Related]
16. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H; J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150 [TBL] [Abstract][Full Text] [Related]
17. Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries. Zekri W; Alfaar AS; Yehia D; Elshafie MM; Zaghloul MS; El-Kinaai N; Taha H; Refaat A; Younes AA Pediatr Blood Cancer; 2014 Dec; 61(12):2185-90. PubMed ID: 25175045 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies. Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918 [TBL] [Abstract][Full Text] [Related]
19. Clear cell sarcoma of the kidney in a 62-year-old patient presenting with generalized pruritus. Zhang Y; Li J; Wang Y BMC Cancer; 2019 Nov; 19(1):1034. PubMed ID: 31676003 [TBL] [Abstract][Full Text] [Related]
20. Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group. Oue T; Fukuzawa M; Okita H; Mugishima H; Horie H; Hata J; Saito M; Nozaki M; Chin M; Nakadate H; Hinotsu S; Koshinaga T; Kaneko Y; Kitano Y; Tanaka Y; Pediatr Surg Int; 2009 Nov; 25(11):923-9. PubMed ID: 19701757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]